Pergoquin
General data
Product class:
Authorized package
Medicinal product class:
Veterinary medicine
Package code:
1782738
Name of medicinal product:
Pergoquin
Active substances:
Pergolide
Estonian
,
English
,
Latin
ATC code:
QN04BC02
Dosage form:
tablet
Route of administration:
oral use
Strengh:
1mg
Amount in package:
200TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Symptomatic treatment of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID) (Equine Cushing’s Disease).
Safety features:
No
Summary of product characteristics (SPC):
(last updated 27 September 2023)
Package information leaflet (PIL):
EST
(last updated 27 September 2023)
Labelling:
(last updated 27 September 2023)
Withdrawal time:
Ei ole lubatud kasutamiseks hobustel, keda tarvitatakse inimtoiduks. Ravitud hobuste tapmine inimtoiduks kasutamise eesmärgil on keelatud. Hobuse passile kohalduvate siseriiklike õigusaktide järgi peab hobune olema deklareeritud mitte inimtoiduks. Ei ole lubatud kasutamiseks märadel, kelle piima tarvitatakse inimtoiduks.
Species:
hobune (muu kui toiduloom)
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Vetviva Richter GmbH
Marketing authorization number:
2202
Marketing authorization issued on:
24 September 2019
Marketing authorization expires on:
24 September 2024
Marketing authorization procedure type:
Decentralised
Entry/Changing date: 22 August 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription